Ambac pares losses in Q4

Ambac saw a fourth-quarter net loss of $2.3 billion, a slight improvement on its performance in the third quarter of 2008, when it lost $2.4 billion and a notable improvement from its showing in the fourth quarter of 2007, when it shed $3.3 billion.

The embattled bond insurer took a $594.4 million charge in the fair value of its credit derivatives portfolio in the period, an improvement on its performance in the prior quarter, when losses from credit derivatives amounted to $2.71 billion.

Ambac also saw $916.4 million in losses as it set aside provisions to cover losses in its residential mortgage-backed securities portfolio, and another $988.5 million as it reduced exposure to credit derivatives contracts.

In November last year, Ambac arranged a deal with counterparties to close out exposure to four collateralised debt obligations (CDOs) with a cash settlement of $1 billion. In a statement, chief executive David Wallis noted that measures taken to reduce risk have contributed to its progress. "The successful commutation of $3.5 billion of CDO of asset-backed securities exposures, including two CDO-squared deals, was constructive and we will continue to pursue this de-risking approach. Equally encouraging have been the remediation efforts on our mortgage exposure which continue to reveal opportunities to recover losses in that portfolio."

The company also stated it is on schedule to launch its municipal-only monoline -Everspan Financial Guarantee - in the second quarter of this year.

See also: Ambac to commute $3.5 billion in CDO exposure
Ambac and MBIA record heavy Q3 losses

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here